Systematic review regarding the relationship between fatalism and glycemic control in adults with type 2 diabetes
DOI:
https://doi.org/10.24875/REIMSS.M21000029Keywords:
Diabetes Mellitus, Type 2, Glycated Hemoglobin A, Adult, Culture, FatalismAbstract
Introduction: Diabetes is currently considered a worldwide emergency due to its increased prevalence, possible complications, and high mortality. Some cultural factors, such as fatalistic beliefs, may represent a barrier to diabetes control.
Objective: Review scientific evidence avaible on the relationship between fatalism and glycemic control in adults with Type 2 Diabetes.
Methods: A search was carried out in EBSCO Academic Search Complete, Science Direct, Web of Science, Pubmed, Springer, Redalyc, Latindex, Mediclatina y Fuente Académica EBSCO, limited to ten years (2008-2018). DeCS and MeHS descriptors were used, the search for studies was in Spanish and English. The studies were evaluated for validity through the Joanna Briggs Institute Critical Assessment guide for cross-sectional analytical studies.
Results: The information query delivered 275 results and 5 from these studies were included. These are correlational-cross-sectional studies, published in English, from countries such as The United States of America, Lebanon, and Israel, which studied between 130 and 615 patients with diagnosis of T2D (between 5 and 14.4 years). Available evidence suggests that there is a relationship between fatalism and glycemic control.
Conclusion: The relationship between fatalism and glycemic control in adults with Type 2 Diabetes is complex and represents, in more fatalistic patients, a barrier to disease control.
References
International Diabetes Federation. IDF Diabetes Atlas, 8th ed [Internet]. 2017 [cited 2019 Mar 3]. Disponible en: https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html
American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(suppl. 1):S13-S28. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/30559228
Organización Mundial de la Salud. Informe mundial sobre la diabetes. World Rep Diabetes [Internet]. 2016;1-84. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/204877/WHO_NMH_NVI_16.3_spa.pdf;jsessionid=1AFA3092C18FAC2DFDC2003A10CDE536?sequence=1
American Diabetes Association. Standards of medical care in diabetes-2020. Diabetes Care. 2020;43(supl1):S1-S43.
American Diabetes Association. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(supl1):S48-S65. Disponible en: https://doi.org/10.2337/dc20-S005
Esparza-Romero J, Valencia ME, Urquídez-Romero R, Chaudhari LS, Hanson RL, Knowler WC, et al. Environmentally driven increases in type 2 diabetes and obesity in pima indians and non-pimas in Mexico over a 15-year period: The Maycoba Project. Diabetes Care. 2015;38(11):2075-82. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/2624657
López-Amador KH, Ocampo-Barrio P. Creencias sobre su enfermedad, hábitos de alimentación, actividad física y tratamiento en un grupo de diabéticos mexicanos. Arch Med Fam. 2007;9(2):80-6. Disponible en: http://www.redalyc.org/articulo.oa?id=50711454003
Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición 2018; trabajo conjunto de INSP e INEGI. México. Disponible en: https://www.insp.mx/avisos/5206-primeros-resultados-ensanut-2018.html
Villalpando S, de la Cruz V, Rojas R, Shamah-Levy T, Avila MA, Gaona B, et al. Prevalence and distribution of type 2 diabetes mellitus in Mexican adult population: a probabilistic survey. Salud Pública Mex. 2010;52(Suppl 1):S19-S26. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20585724
American Diabetes Association. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13-S28. Disponible en: https://care.diabetesjournals.org/content/42/Supplement_1/S13
Jiménez-Corona A, Aguilar-Salinas CA, Rojas-Martínez R, Hernández-Ávila M. Diabetes mellitus tipo 2 y frecuencia de acciones para su prevención y control. Salud Pública Mex. 2013; 55(supl 2):S137-S143. Disponible en: http://www.scielo.org.mx/pdf/spm/v55s2/v55s2a10.pdf
American Diabetes Association. Diabetes Control and Complications Trial (DCCT). Update. Diabetes Care. 1990;13(4):427-33. Disponible en: https://care.diabetesjournals.org/content/13/4/427
Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Zárate-Rojas E, Villalpando S, Barrientos-Gutiérrez T. Prevalencia de diabetes por diagnóstico médico previo en México. Salud Pública Mex. 2018;60(3):224-32. Disponible en: http://www.saludpublica.mx/index.php/spm/article/view/8566
Organización Mundial de la Salud. Diabetes [Internet]. 2016 [cited 2019 Mar 25]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/204877/WHO_NMH_NVI_16.3_spa.pdf?sequence=1
Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu Ch, Mingrone G, et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41(12):2669-701. Disponible en: https://care.diabetesjournals.org/content/41/12/2669
Beck J, Greenwood DA, Blanton L, Bollinger ST, Butcher MK, Condon JE, et al. National standards for diabetes self-management education and support. Diabetes Care. 2017;40(10):1409-19. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/28754780
Caballero AE. The “A to Z” of managing type 2 diabetes in culturally diverse populations. Front Endocrinol. 2018;9:479. doi:10.3389/fendo.2018.00479 Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/30233490
White LA. The concept of culture. Am Anthropol. 1959;61(2):227-51. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1525/aa.1959.61.2.02a00040
Calvete E, Cardeñoso O. Creencias, resolución de problemas sociales y correlatos psicológicos. Psicothema. 2001;1381:95-1000. Disponible en: http://www.psicothema.com/psicothema.asp?id=419
Beck AT, Haigh EAP. Advances in cognitive theory and therapy: the generic cognitive model. Annu Rev Clin Psychol. 2014;10:1-24. Disponible en: http://www.annualreviews.org/doi/10.1146/annurev-clinpsy-032813-153734
Moreno-San Pedro E, Roales-Nieto JG. El modelo de creencias de salud: revisión teórica, consideración crítica y propuesta alternativa, hacia un análisis funcional de las creencias en salud. Rev Int Psicol Ter Psicol. 2003;3(1):91-109. Disponible en: https://www.ijpsy.com/volumen3/num1/59/el-modelo-de-creencias-de-salud-revisi-ES.pdf
Cummings KM, Jette AM, Rosenstock IM. Construct validation of the health belief model. Health Educ Monogr. 1978;6(4):394-405. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/299611
Egede LE, Bonadonna RJ. Diabetes self-management in african americans: an exploration of the role of fatalism. Diabetes Educ. 2003;29(1):105-15. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/12632689
Ojikutu B, Nnaji C, Sithole-Berk J, Bogart LM, Gona P. Barriers to HIV testing in black immigrants to the U.S. J Health Care Poor Underserved. 2014;25(3):1052-1066. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/25130224
Powe BD, Finnie R. Cancer fatalism: the state of the science. Cancer Nurs. 2003;26(6):454-465. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/15022977
Ramírez AS, Arellano-Carmona K. Beyond fatalism: Information overload as a mechanism to understand health disparities. Soc Sci Med. 2018;219:11-18. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/30342382
Esparza-Del Villar OA, Quiñónez-Soto J, Carrillo-Saucedo IC. Propiedades psicométricas de la escala multidimensional de fatalismo y su relación con comportamientos de la salud. Colección Textos Universitarios, serie Investigación. Universidad Autónoma de Ciudad Juárez, Chihuahua, México, 2010
Egede LE, Ellis C. Development and psychometric properties of the 12-item diabetes fatalism scale. J Gen Intern Med. 2010;25(1):61-6. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19908102
Sukkarieh-Haraty O, Egede LE, Abi Kharma J, Bassil M. Psychometric properties of the Arabic version of the 12-item diabetes fatalism scale. PLoS One. 2018;13(1). Disponible en: https://dx.plos.org/10.1371/journal.pone.0190719
Walker RJ, Smalls BL, Hernández-Tejada MA, Campbell JA, Davis KS, Egede LE. Effect of diabetes fatalism on medication adherence and self-care behaviors in adults with diabetes. Gen Hosp Psychiatry. 2012;34(6):598-603. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22898447
Ferreira-González I, Urrutia G, Alonso-Coello P. Revisiones sistemáticas y metaanálisis: bases conceptuales e interpretación. Rev Española Cardiol. 2011;64:688-96. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0300893211004507
The University of Adelaide. Critical Appraisal Tools, Joanna Briggs Institute. [cited 2019 Jul 31]. Disponible en: https://joannabriggs.org/critical-appraisal-tools
Asuzu CC, Walker RJ, Williams JS, Egede LE. Pathways for the relationship between diabetes distress, depression, fatalism and glycemic control in adults with type 2 diabetes. J Diabetes Complications. 2017;31(1):169-74. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/27746088
Berardi V, Bellettiere J, Nativ O, Ladislav S, Hovell MF, Baron-Epel O. Fatalism, diabetes management outcomes, and the role of religiosity. J Relig Health. 2016;55(2):602-17. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/26002058
Osborn CY, Egede LE. Validation of an information-motivation-behavioral skills model of diabetes self-care (IMB-DSC). Patient Educ Couns. 2010;79(1):49-54. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19699601
Grove SK, Gray JR, Burns N. Understanding nursing research: building an evidence-based practice. Elsevier Health Sciences, 2015. Disponible en: https://books.google.com/books?id=LjKPBAAAQBAJ&pgis=1
Prieto-Macías J, Terrones-Saldívar MC, Valdez-Bocanegra JD, Valdez-Sandoval DA, Hernández-González F, Reyes-Robles ME. Frecuencia de complicaciones en pacientes con diabetes mellitus tipo 2 de un hospital de segundo nivel en Aguascalientes. Lux Médica. 2017;35(12):19-27. Disponible en: https://revistas.uaa.mx/index.php/luxmedica/article/view/621
American Diabetes Association. Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S1-S2. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/30559224
Sukkarieh-Haraty O, Egede LE, Abi Kharma J, Bassil M. Predictors of diabetes fatalism among arabs: a cross-sectional study of lebanese adults with type 2 diabetes. J Relig Health. 2018;57(3):858-68. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/28597199
Walker RJ, Smalls BL, Egede LE. Social determinants of health in adults with type 2 diabetes-contribution of mutable and immutable factors. Diabetes Research and Clinical Practice. 2015; DOI:http://dx.doi.org/10.1016/j.diabres.2015.09.007
Caballero AE. Type 2 diabetes in the hispanic or latino population: challenges and opportunities. Curr Opin Endocrinol Diabetes Obes. 2007;14(2):151-7. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/17940434
McCloskey J, Flenniken D. Overcoming cultural barriers to diabetes control: a qualitative study of southwestern New Mexico Hispanics. J Cult Divers. 2010;17(3):110-5. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/20860336
Rustveld LO, Pavlik VN, Jibaja-Weiss ML, Kline KN, Gossey JT, Volk RJ. Adherence to diabetes self-care behaviors in english- and spanish-speaking Hispanic men. Patient Prefer Adherence. 2009;3:123-30. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19936154
Manterola C, Otzen T. Los sesgos en investigación clínica. Int J Morphol. 2015;33(3):1156-1164. Disponible en: https://scielo.conicyt.cl/pdf/ijmorphol/v33n3/art56.pdf
Álvarez-Hernández G, Delgado-De la Mora J. Diseño de estudios epidemiológicos. I. El estudio transversal: tomando una fotografía de la salud y la enfermedad. Bol Clin Hosp Infant Edo Son. 2015;32(1):26-34. Disponible en: https://www.medigraphic.com/pdfs/bolclinhosinfson/bis-2015/bis151f.pdf
